Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis

Luis E. Simental-Mendía, Antonio M. Gotto, Stephen Atkin, Maciej Banach, Matteo Pirro, Amirhossein Sahebkar

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Background: Soy supplementation has been shown to reduce total and low-density lipoprotein cholesterol, while increasing high-density lipoprotein cholesterol. However, contradictory effects of soy isoflavone supplementation on lipoprotein(a) [Lp(a)] have been reported suggesting the need for a meta-analysis to be undertaken. Objective: The aim of the study was to investigate the impact of supplementation with soy isoflavones on plasma Lp(a) levels through a systematic review and meta-analysis of eligible randomized placebo-controlled trials. Methods: The search included PubMed–Medline, Scopus, ISI Web of Knowledge, and Google Scholar databases (by March 26, 2017), and quality of studies was evaluated according to Cochrane criteria. Quantitative data synthesis was performed using a random-effects model, with standardized mean difference and 95% confidence interval as summary statistics. Meta-regression and leave-one-out sensitivity analysis were performed to assess the modifiers of treatment response. Results: Ten eligible studies comprising 11 treatment arms with 973 subjects were selected for the meta-analysis. Meta-analysis did not suggest any significant alteration of plasma Lp(a) levels after supplementation with soy isoflavones (standardized mean difference: 0.08, 95% confidence interval: −0.05, 0.20, P = .228). The effect size was robust in the leave-one-out sensitivity analysis. In meta-regression analysis, neither dose nor duration of supplementation with soy isoflavones was significantly associated with the effect size. Conclusion: This meta-analysis of the 10 available randomized placebo-controlled trials revealed no significant effect of soy isoflavones treatment on plasma Lp(a) concentrations.

Original languageEnglish
Pages (from-to)16-24
Number of pages9
JournalJournal of Clinical Lipidology
Volume12
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Fingerprint

Lipoprotein(a)
Isoflavones
Meta-Analysis
Randomized Controlled Trials
Placebos
Confidence Intervals
LDL Cholesterol
HDL Cholesterol
Therapeutics
Regression Analysis
Databases

Keywords

  • Cardiovascular disease
  • Lipoprotein(a)
  • Meta-analysis
  • Soy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Cardiology and Cardiovascular Medicine

Cite this

Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations : A meta-analysis. / Simental-Mendía, Luis E.; Gotto, Antonio M.; Atkin, Stephen; Banach, Maciej; Pirro, Matteo; Sahebkar, Amirhossein.

In: Journal of Clinical Lipidology, Vol. 12, No. 1, 01.01.2018, p. 16-24.

Research output: Contribution to journalReview article

Simental-Mendía, Luis E. ; Gotto, Antonio M. ; Atkin, Stephen ; Banach, Maciej ; Pirro, Matteo ; Sahebkar, Amirhossein. / Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations : A meta-analysis. In: Journal of Clinical Lipidology. 2018 ; Vol. 12, No. 1. pp. 16-24.
@article{2b7cb6eb4bc1470f87748bd4b2d83fb0,
title = "Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis",
abstract = "Background: Soy supplementation has been shown to reduce total and low-density lipoprotein cholesterol, while increasing high-density lipoprotein cholesterol. However, contradictory effects of soy isoflavone supplementation on lipoprotein(a) [Lp(a)] have been reported suggesting the need for a meta-analysis to be undertaken. Objective: The aim of the study was to investigate the impact of supplementation with soy isoflavones on plasma Lp(a) levels through a systematic review and meta-analysis of eligible randomized placebo-controlled trials. Methods: The search included PubMed–Medline, Scopus, ISI Web of Knowledge, and Google Scholar databases (by March 26, 2017), and quality of studies was evaluated according to Cochrane criteria. Quantitative data synthesis was performed using a random-effects model, with standardized mean difference and 95{\%} confidence interval as summary statistics. Meta-regression and leave-one-out sensitivity analysis were performed to assess the modifiers of treatment response. Results: Ten eligible studies comprising 11 treatment arms with 973 subjects were selected for the meta-analysis. Meta-analysis did not suggest any significant alteration of plasma Lp(a) levels after supplementation with soy isoflavones (standardized mean difference: 0.08, 95{\%} confidence interval: −0.05, 0.20, P = .228). The effect size was robust in the leave-one-out sensitivity analysis. In meta-regression analysis, neither dose nor duration of supplementation with soy isoflavones was significantly associated with the effect size. Conclusion: This meta-analysis of the 10 available randomized placebo-controlled trials revealed no significant effect of soy isoflavones treatment on plasma Lp(a) concentrations.",
keywords = "Cardiovascular disease, Lipoprotein(a), Meta-analysis, Soy",
author = "Simental-Mend{\'i}a, {Luis E.} and Gotto, {Antonio M.} and Stephen Atkin and Maciej Banach and Matteo Pirro and Amirhossein Sahebkar",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jacl.2017.10.004",
language = "English",
volume = "12",
pages = "16--24",
journal = "Journal of Clinical Lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations

T2 - A meta-analysis

AU - Simental-Mendía, Luis E.

AU - Gotto, Antonio M.

AU - Atkin, Stephen

AU - Banach, Maciej

AU - Pirro, Matteo

AU - Sahebkar, Amirhossein

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Soy supplementation has been shown to reduce total and low-density lipoprotein cholesterol, while increasing high-density lipoprotein cholesterol. However, contradictory effects of soy isoflavone supplementation on lipoprotein(a) [Lp(a)] have been reported suggesting the need for a meta-analysis to be undertaken. Objective: The aim of the study was to investigate the impact of supplementation with soy isoflavones on plasma Lp(a) levels through a systematic review and meta-analysis of eligible randomized placebo-controlled trials. Methods: The search included PubMed–Medline, Scopus, ISI Web of Knowledge, and Google Scholar databases (by March 26, 2017), and quality of studies was evaluated according to Cochrane criteria. Quantitative data synthesis was performed using a random-effects model, with standardized mean difference and 95% confidence interval as summary statistics. Meta-regression and leave-one-out sensitivity analysis were performed to assess the modifiers of treatment response. Results: Ten eligible studies comprising 11 treatment arms with 973 subjects were selected for the meta-analysis. Meta-analysis did not suggest any significant alteration of plasma Lp(a) levels after supplementation with soy isoflavones (standardized mean difference: 0.08, 95% confidence interval: −0.05, 0.20, P = .228). The effect size was robust in the leave-one-out sensitivity analysis. In meta-regression analysis, neither dose nor duration of supplementation with soy isoflavones was significantly associated with the effect size. Conclusion: This meta-analysis of the 10 available randomized placebo-controlled trials revealed no significant effect of soy isoflavones treatment on plasma Lp(a) concentrations.

AB - Background: Soy supplementation has been shown to reduce total and low-density lipoprotein cholesterol, while increasing high-density lipoprotein cholesterol. However, contradictory effects of soy isoflavone supplementation on lipoprotein(a) [Lp(a)] have been reported suggesting the need for a meta-analysis to be undertaken. Objective: The aim of the study was to investigate the impact of supplementation with soy isoflavones on plasma Lp(a) levels through a systematic review and meta-analysis of eligible randomized placebo-controlled trials. Methods: The search included PubMed–Medline, Scopus, ISI Web of Knowledge, and Google Scholar databases (by March 26, 2017), and quality of studies was evaluated according to Cochrane criteria. Quantitative data synthesis was performed using a random-effects model, with standardized mean difference and 95% confidence interval as summary statistics. Meta-regression and leave-one-out sensitivity analysis were performed to assess the modifiers of treatment response. Results: Ten eligible studies comprising 11 treatment arms with 973 subjects were selected for the meta-analysis. Meta-analysis did not suggest any significant alteration of plasma Lp(a) levels after supplementation with soy isoflavones (standardized mean difference: 0.08, 95% confidence interval: −0.05, 0.20, P = .228). The effect size was robust in the leave-one-out sensitivity analysis. In meta-regression analysis, neither dose nor duration of supplementation with soy isoflavones was significantly associated with the effect size. Conclusion: This meta-analysis of the 10 available randomized placebo-controlled trials revealed no significant effect of soy isoflavones treatment on plasma Lp(a) concentrations.

KW - Cardiovascular disease

KW - Lipoprotein(a)

KW - Meta-analysis

KW - Soy

UR - http://www.scopus.com/inward/record.url?scp=85033387611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033387611&partnerID=8YFLogxK

U2 - 10.1016/j.jacl.2017.10.004

DO - 10.1016/j.jacl.2017.10.004

M3 - Review article

AN - SCOPUS:85033387611

VL - 12

SP - 16

EP - 24

JO - Journal of Clinical Lipidology

JF - Journal of Clinical Lipidology

SN - 1933-2874

IS - 1

ER -